Frederick Pierce's most recent trade in Decoy Therapeutics Inc. was a trade of 33,455 Common Stock done . Disclosure was reported to the exchange on Aug. 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Decoy Therapeutics Inc | Frederick Pierce | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2026 | 33,455 | 34,844 (0%) | 0% | 0 | Common Stock |